The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.
The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief of eye redness due to minor irritation in individuals aged 12 years and ...
Subcutaneous interleukin-6 receptor antagonist approved for adult patients with active or inactive thyroid eye disease regardless of disease duration.
No over-the-counter product can treat genital herpes or any other sexually transmitted infection, regulators say ...
A nationwide voluntary recall has been issued for 22 lots of Argatroban Injection due to the presence of multi-material particulate contamination, posing potential life-threatening risks.
The expansion marks the first therapy approved for patients with BCG-unresponsive non-muscle-invasive bladder cancer presenting with papillary-only disease.
Immediate symptomatic relief and long-term neuroimmunomodulation seen with acupressure combined with pharmacotherapy ...
Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...
Real-world GPP data show low uptake of targeted IL-36 inhibitors and persistent reliance on corticosteroids and non-GPP ...
Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...
Risk for ischemic stroke, myocardial infarction were increased with prolonged use with doses >1 mg/day for more than one year ...
Dr Ablon discusses important key points providers should keep in mind during their evaluations of patients seeking aesthetic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results